Evidence map›Paper›PMID 32549795›Full record

ReviewReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part II on Urological Management).

Marc J Rogers, Marigdalia K Ramirez-Fort, James A Kashanian, Seth A Broster, Jaime Matta, Sean S Mahase, Digna V Fort, M Junaid Niaz, Shearwood McClelland, Neil H Bander and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Marc J RogersUrology, Medical University of South Carolina, Charleston, SC, United States.
Marigdalia K Ramirez-FortLife Sciences, BioFort Corp., Guaynabo, PR, United States.
James A KashanianUrology, Weill Cornell Medicine, New York, NY, United States.
Seth A BrosterUrology, Medical University of South Carolina, Charleston, SC, United States.
Jaime MattaPharmacology and Toxicology, Ponce Health Sciences University, Ponce, PR, United States.
Sean S MahaseRadiation Oncology, Weill Cornell Medicine, New York, NY, United States.
Digna V FortLife Sciences, BioFort Corp., Guaynabo, PR, United States.
M Junaid NiazUrology, Weill Cornell Medicine, New York, NY, United States.
Shearwood McClellandRadiation Oncology, Indiana University, Indianapolis, IN, United States.
Neil H BanderUrology, Weill Cornell Medicine, New York, NY, United States.
Migdalia FortLife Sciences, BioFort Corp., Guaynabo, PR, United States.
Christopher S LangeLife Sciences, BioFort Corp., Guaynabo, PR, United States.
Peter SchlegelUrology, Weill Cornell Medicine, New York, NY, United States.
John P MulhallSexual and Reproductive Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Cornell University · USMedical University of South Carolina · USSUNY Downstate Health Sciences University · USIndiana University – Purdue University Indianapolis · USMemorial Sloan Kettering Cancer Center · USPonce Health Sciences University · PR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Prostate cancer is the most common malignancy in men and the second leading cause of cancer-related death in men. Radiotherapy is a curative option that is administered via external beam radiation, brachytherapy, or in combination. Sexual dysfunction is a common toxicity following radiotherapy, similar to men undergoing radical prostatectomy, but the etiology is different. The pathophysiology of radiation-induced sexual dysfunction is multi-factorial, and the toxicity is a major cause of impaired quality of life among long-term prostate cancer survivors. Management of a patient's sexual function during and after radiotherapy requires multidisciplinary coordination of care between radiation oncology, urology, psychiatry, pharmacy, and dermatology. This review provides a framework for clinicians to better understand prostatic radiotherapy-induced sexual dysfunction diagnosis, evaluation, and a patient-centered approach to toxicity preventive strategies and management.

Indexed as

Ejaculatory dysfunctionErectile dysfunctionIntracavernosal InjectionsOrgasmic dysfunctionPDE-5iPenile prosthesisPenile Vibratory stimulationProstate cancerRadiation therapySexual ToxicitiesVacuum erection device

Identifiers

PMID32549795
PMCPMC7286930
OpenAlexW3022137003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.